Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Genomics, Proteomics & Bioinformatics
|
April 8, 2017
GSA: Genome Sequence Archive<sup/>
Yanqing Wang, Fuhai Song, Junwei Zhu, et al.
Journal of Hematology & Oncology
|
January 16, 2019
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients
Bixia Tang, Xieqiao Yan, Xinan Sheng, et al.
Journal for Immunotherapy of Cancer
|
October 4, 2024
Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial
Bixia Tang, Yu Chen, Yu Jiang, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Jie Dai, Xue Bai, Xuan Gao, et al.
Annals of Surgical Oncology
|
April 10, 2022
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal
ChuanLiang Cui, Bin Lian, XiaoShi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2019
Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
Jiayi Yu, Junya Yan, Qian Guo, et al.
JAMA Oncology
|
June 1, 2023
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial
Lili Mao, Bin Lian, Caili Li, et al.
Journal of the American Academy of Dermatology
|
September 8, 2022
Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis
Xiaoting Wei, Yu Chen, Hong Yao, et al.
Nature Communications
|
May 15, 2026
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma
Lili Mao, Yumei Lai, Hong Zheng, et al.
Annals of Surgical Oncology
|
April 8, 2020
The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma
Xiaoting Wei, Di Wu, Hang Li, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Genomics, Proteomics & Bioinformatics
|
April 8, 2017
GSA: Genome Sequence Archive<sup/>
Yanqing Wang, Fuhai Song, Junwei Zhu, et al.
Journal of Hematology & Oncology
|
January 16, 2019
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients
Bixia Tang, Xieqiao Yan, Xinan Sheng, et al.
Journal for Immunotherapy of Cancer
|
October 4, 2024
Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial
Bixia Tang, Yu Chen, Yu Jiang, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Jie Dai, Xue Bai, Xuan Gao, et al.
Annals of Surgical Oncology
|
April 10, 2022
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal
ChuanLiang Cui, Bin Lian, XiaoShi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2019
Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
Jiayi Yu, Junya Yan, Qian Guo, et al.
JAMA Oncology
|
June 1, 2023
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial
Lili Mao, Bin Lian, Caili Li, et al.
Journal of the American Academy of Dermatology
|
September 8, 2022
Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis
Xiaoting Wei, Yu Chen, Hong Yao, et al.
Nature Communications
|
May 15, 2026
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma
Lili Mao, Yumei Lai, Hong Zheng, et al.
Annals of Surgical Oncology
|
April 8, 2020
The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma
Xiaoting Wei, Di Wu, Hang Li, et al.
Page
of 12